Vicebio

About:

Vicebio is committed to employing the Molecular Clamp Technology to create vaccines against next-generation respiratory viruses.

Website: https://vicebio.com/

Top Investors: Goldman Sachs Alternatives, TCG Crossover, venBio Partners, Medicxi, UniQuest

Description:

Vicebio is committed to employing the Molecular Clamp Technology to create vaccines against next-generation respiratory viruses. Vicebio is a biopharmaceutical business that creates innovative vaccinations to prevent potentially fatal respiratory viral infections.